Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Jessica M Hislop

2PUBLICATIONS

7CO-AUTHORS

Haematological tumoursHaematology

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Oct 18, 2024

Appraising ascorbic acid as a chemoprevention agent for acute myeloid leukaemia using Mendelian Randomisation.

Sina A Beer, Molly Went, Jessica M Hislop

|Jul 16, 2024

Using Mendelian Randomisation to search for modifiable risk factors influencing the development of clonal haematopoiesis.

Jessica M Hislop, Molly Went, Charlie Mills

Pageof 1

Frequent Collaborators

2 joint publications

Molly Went

2 joint publications

Richard S Houlston

1 joint publications

Charlie Mills

1 joint publications

Amit Sud

1 joint publications

Philip J Law

1 joint publications

Sina A Beer

1 joint publications

Martin Kaiser

Frequent Collaborators

2 joint publications

Molly Went

2 joint publications

Richard S Houlston

1 joint publications

Charlie Mills

1 joint publications

Amit Sud

Top Related Videos

Modeling Chemotherapy Resistant Leukemia <em>In Vitro</em>

Modeling Chemotherapy Resistant Leukemia <em>In Vitro</em>

Published on : Feb 09, 2016

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models

Published on : Oct 03, 2019

See more related videos

Top Related Videos

Modeling Chemotherapy Resistant Leukemia <em>In Vitro</em>

Modeling Chemotherapy Resistant Leukemia <em>In Vitro</em>

Published on : Feb 09, 2016

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models

Published on : Oct 03, 2019

See more related videos